MACERICH Earnings Results: $MAC Reports Quarterly Earnings

MACERICH ($MAC) posted quarterly earnings results on Thursday, February 27th. The company reported earnings of $0.47 per share, beating estimates of $0.05 by $0.42. The company also reported revenue of $273,680,000, beating estimates of $225,330,828 by $48,349,172.

You can see Quiver Quantitative's $MAC stock page to track data on insider trading, hedge fund activity, congressional trading, and more.

MACERICH Insider Trading Activity

MACERICH insiders have traded $MAC stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $MAC stock by insiders over the last 6 months:

• ANDREA M STEPHEN sold 63,289 shares for an estimated $1,303,120

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

MACERICH Hedge Fund Activity

We have seen 182 institutional investors add shares of MACERICH stock to their portfolio, and 121 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• FMR LLC added 10,274,895 shares (+87.3%) to their portfolio in Q4 2024, for an estimated $204,675,908
• WELLINGTON MANAGEMENT GROUP LLP added 8,988,665 shares (+845.9%) to their portfolio in Q4 2024, for an estimated $179,054,206
• BLACKROCK, INC. added 5,657,152 shares (+14.1%) to their portfolio in Q4 2024, for an estimated $112,690,467
• VANGUARD GROUP INC added 4,503,509 shares (+13.2%) to their portfolio in Q4 2024, for an estimated $89,709,899
• BAMCO INC /NY/ added 2,980,051 shares (+175.8%) to their portfolio in Q4 2024, for an estimated $59,362,615
• PRUDENTIAL FINANCIAL INC added 2,131,030 shares (+463.6%) to their portfolio in Q4 2024, for an estimated $42,450,117
• JPMORGAN CHASE & CO added 1,667,066 shares (+77.7%) to their portfolio in Q4 2024, for an estimated $33,207,954

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.